Notably, interfering with macrophage-iNKT cell interactions in addition to knocking down Vcam1 in MC38 tumor cells further enhanced anti-tumor efficacy of iNKT cells (Fig. 9a–d). This evidence concerns the gene VCAM1 and neoplasm.